| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.5 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.5 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.5 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |